Jernigan A D, Wilson R C, Hatch R C
Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens 30602.
Am J Vet Res. 1988 Mar;49(3):355-8.
Six mixed-breed adult cats were given 5 mg of amikacin sulfate/kg of body weight by rapid IV, IM, and SC routes of administration. The serum concentration-vs-time data were analyzed, using a noncompartmental model. The harmonic mean +/- pseudo-SD of the effective half-life of amikacin was 78.8 +/- 19.3 minutes after IV administration, 118.7 +/- 14.4 minutes after IM administration, and 117.7 +/- 12.8 minutes after SC administration. The arithmetic mean +/- SD of mean residence time was 118.3 +/- 21.7 minutes, 173.4 +/- 19.9 minutes, and 171.7 +/- 19.1 minutes after IV, IM, and SC drug administration, respectively. The mean apparent volume of distribution at steady state was 0.17 +/- 0.02 L/kg, and the mean total body clearance was 1.46 +/- 0.26 ml/min/kg. Mean bioavailability was 95 +/- 20% after IM administration and 123 +/- 33% after SC drug administration. A recommended dosage of 10 mg/kg, q 8 h can be expected to provide a therapeutic serum concentration of amikacin with a mean steady-state concentration of 14 micrograms/ml. The SC route of administration is preferred, because of rapid absorption, good bioavailability, and ease of administration.
六只成年杂种猫通过静脉快速注射、肌肉注射和皮下注射途径,给予硫酸阿米卡星5毫克/千克体重。采用非房室模型分析血清浓度-时间数据。静脉注射后,阿米卡星有效半衰期的调和均值±伪标准差为78.8±19.3分钟;肌肉注射后为118.7±14.4分钟;皮下注射后为117.7±12.8分钟。静脉注射、肌肉注射和皮下注射给药后,平均驻留时间的算术均值±标准差分别为118.3±21.7分钟、173.4±19.9分钟和171.7±19.1分钟。稳态时的平均表观分布容积为0.17±0.02升/千克,平均全身清除率为1.46±0.26毫升/分钟/千克。肌肉注射后的平均生物利用度为95±20%,皮下注射给药后的平均生物利用度为123±33%。推荐剂量为10毫克/千克,每8小时一次,预计可提供治疗性血清阿米卡星浓度,平均稳态浓度为14微克/毫升。由于吸收迅速、生物利用度良好且易于给药,皮下注射途径为首选。